Sort
15,842 grants matching “pancreatic cancer”
The Role of Guanine Exchange Factors in Pancreatic Ductal Adenocarcinoma (PDAC)
$52,538Sahar Bannoura · Wayne State University · F99 · FY2025 · CA
Smoking and pancreatic cancer
$52,429Surinder Kumar Batra · University Of Nebraska Medical Center · R01 · FY2010 · CA
K-Ras mutant-specific vulnerabilities for novel pancreatic cancer therapies
$52,406Guy Aaron Hobbs · Univ Of North Carolina Chapel Hill · F32 · FY2015 · CA
Novel BPTES Analogs for the Treatment of Pancreatic Cancer
$52,406Sarah Zimmermann · Johns Hopkins University · F32 · FY2015 · CA
Mechanisms of tumor suppression by epigenetic regulators in pancreatic cancer
$52,190Geulah Yevgeniya Livshits · Sloan-Kettering Inst Can Research · F32 · FY2013 · CA
Mechanisms of Lkb1 function in lymphocytes in the context of Kras activation
$52,190George P. Souroullas · Univ Of North Carolina Chapel Hill · F32 · FY2013 · HL
Autophagy and human islet amyloid polypeptide in animal models of type 2 diabetes
$52,154Jacqueline Rivera · University Of California Los Angeles · F32 · FY2010 · DK
RAGE Mediated Mechanisms of Islet Amyloid Polypeptide Cytotoxicity in Type 2 Diab
$52,154Andisheh Abedini · New York University School Of Medicine · F32 · FY2010 · DK
Origin of Pancreatic Ductal Adenocarcinoma
$52,154Janel Lynn Kopp · University Of California, San Diego · F32 · FY2010 · CA
MBQ-167 derivatives as antimetastatic cancer agents.
$52,150Suranganie F Dharmawardhane · University Of Puerto Rico Med Sciences · R16 · FY2025 · GM
Cancer cell signaling through lipids complexed to proteins
$52,094Raymond Daniel Blind · Vanderbilt University Medical Center · K01 · FY2015 · CA
Radiometal-cyclized Octreotide Derivatives for Oncology
$52,048Heather M Hennkens · University Of Missouri-Columbia · F32 · FY2008 · CA
Development of a pancreatic cancer vaccine
$52,048Kira R Gantt · University Of Pittsburgh At Pittsburgh · F32 · FY2006 · CA
Using Targeted Lipid Nanoparticles to Deliver Chemotherapeutic Agents against Pancreatic Cancer
$52,000Maria Lambros · Doricpharma Llc · R41 · FY2021 · CA
Development of personalized ex vivo predictive technology for rapidly matching patient tumors with chemotherapy regimens before treatment.
$52,000Karim I Budhwani · Cerflux, Inc. · R43 · FY2021 · CA
THE ROLE OF FAN1 NUCLEASE IN KIDNEY AND DIGESTIVE SYSTEM HEALTH AND FUNCTION
$51,991Ryan Richard White · Rockefeller University · F32 · FY2019 · DK
A platform for image-guided, magneto-acoustic gene therapy of pancreatic cancer
$51,894Beata Chertok · Massachusetts Institute Of Technology · F32 · FY2012 · EB
Identifying the Role of Tumor Cell Intrinsic DNMT1 in Anti-Tumor Immunity in Pancreatic Ductal Adenocarcinoma
$51,752Erin Elizabeth Hollander · University Of Pennsylvania · F30 · FY2022 · CA
Elucidating the protective role of stromal fibrosis to radiation-induced tumor immunity
$51,752Varintra Edlyn Lander · Washington University · F30 · FY2022 · CA
The Potential Role of Firboblast Activation Protein as a Natural Killer Cell Immune Checkpoint in Pancreatic Cancer
$51,752Allison O'Connell · Georgetown University · F30 · FY2022 · CA
Augmenting Pancreatic Cancer Immunotherapy via TGFβ Pathway Inhibition
$51,752Daniel R Principe · University Of Illinois At Chicago · F30 · FY2022 · CA
Mechanistic study of TCR signaling strength in CD8 T cell differentiation during pathogenesis of T1DM
$51,752Moujtaba Y Kasmani · Medical College Of Wisconsin · F30 · FY2022 · DK
Harnessing Dendritic Cells as a Novel Therapy in Pancreatic Ductal Adenocarcinoma
$51,752Graham Douglas Hogg · Washington University · F30 · FY2022 · CA
Role of GSK-3 isoforms in Pancreatic Cancer
$51,733Muthusamy Kunnimalaiyaan · Medical College Of Wisconsin · R03 · FY2012 · CA
Conformational based design and development of antitumor agents
$51,724Shelli R McAlpine · San Diego State University · R01 · FY2011 · CA